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Abstract
Background: Cross-sectional evidence has shown an association between abdominal obesity and lower muscle strength in older adults. 
However, no longitudinal findings have confirmed this association. In addition, the impact of abdominal fat on the reduction in muscle strength 
is not yet fully understood.
Methods: We investigated the longitudinal associations between abdominal obesity and handgrip strength in 5,181 older adults from the 
English Longitudinal Study of Ageing over 8 years of follow-up. Muscular strength was measured using a manual dynamometer. Abdominal 
obesity was defined as a waist circumference >102 cm for men and >88 cm for women. Generalized linear mixed models were adjusted by 
measures of socioeconomic status, health conditions, lifestyle, cognition, depressive symptoms, biomarkers, and disability.
Results: At baseline, the mean age of participants was 65.8 years and their mean waist circumference and body mass index (BMI) were 95 cm 
and 27.7 kg/m2, respectively. Fully adjusted models showed that abdominal obese men and women had stronger muscle strength at baseline. 
The decline over time in muscle strength was accelerated in abdominal obese men (−0.12 kg/year, 95% confidence interval: −0.24 to −0.01) 
compared with nonabdominal obese. This association was not found in women. Comparative analyses showed that overweight men according 
to their BMI were not at greater risk of muscle strength decline. However, these men were at risk based on their waist circumference.
Conclusions: Abdominal obesity is associated with accelerated muscle strength decline in men.
Keywords: Grip strength, Waist circumference, Longitudinal, Trajectories.
Muscle strength and muscle mass decline with aging. The decline is 
faster for muscle strength, and it is strongly associated with disability 
and death (1,2). Gender differences are found in terms of absolute 
levels of muscle strength as well as loss of strength over time, both 
greater among men (1,3,4). However, the mechanisms underlying 
these differences and the effect on functional muscle properties are 
not yet fully understood (1,4).
Musculoskeletal aging has been accompanied by increas-
ing obesity in older adults globally (5). The relationship between 
muscle strength and adiposity has been explored, but the strength 
of this association varies according to the anthropometric measure 
adopted, that is, body mass index (BMI) or waist circumference. 
Cross-sectional findings from 8,441 participants from the European 
Prospective Investigation into Cancer-Norfolk Study (4) showed that 
higher BMI was associated with stronger grip strength, but a larger 
waist circumference was associated with a weaker handgrip.
Recent evidence shows that abdominal fat contributes to a greater 
loss of muscle strength via neuroendocrine dysregulations (3,6). 
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In addition, there are gender differences related to abdominal fat 
deposition patterns. Women accumulate more subcutaneous fat, 
whereas men accumulate more visceral fat (5). Such differences 
could also play a role in the different speed of muscle strength 
decline between men and women.
To the best of our knowledge, this is the first longitudinal study 
to investigate whether abdominal obesity accelerates muscle strength 
decline among older adults over a period of 8 years of follow-up.
Methods
Study Population
The English Longitudinal Study of Ageing (ELSA) is an ongoing lon-
gitudinal panel study of community-dwelling people aged 50 years 
and older in England that commenced in 2002. ELSA sample was 
drawn from participants who had previously participated in the 
Health Survey for England (HSE) (7), an annual health examination 
survey that each year recruits a different nationally representative 
sample using a multistage stratified random probability design. After 
baseline, follow-up interviews within ELSA occur every 2 years and 
health examinations, that is, a nurse visit, every 4 years. The first 
health examination was in 2004–2005. A detailed description of the 
study can be found elsewhere (7). Analyses for this study included 
longitudinal data from Waves 2 (2004–2005), 4 (2008–2009), and 
6 (2012–2013). All ELSA participants gave written informed con-
sent. The National Research and Ethics Committee granted Ethical 
approval for all the ELSA waves (MREC/01/2/91).
Assessment of Muscle Strength
Grip strength (kilograms) was measured three times for each hand 
using the Smedley dynamometer. During the test, the participant 
remained standing with the arm alongside the trunk and elbow at 
90 degrees (8). Three maximum strength tests were performed with 
a 1-minute rest between tests, and the highest strength value in the 
dominant hand was used in our analysis.
Waist Circumference Assessment
Waist circumference (centimeters) was determined using a flexible 
metric tape at the midpoint between the iliac crest and last rib. The 
participant remained standing with arms alongside the body and 
the trunk free of clothing. The measurement was performed with 
the abdomen relaxed at the end of expiration (8). Abdominal obe-
sity was defined as a waist circumference >88 cm for women and 
>102 cm for men (9).
Covariates
Sociodemographic covariates were age (years), marital status (with 
or without conjugal life), household wealth (quintiles), and educa-
tion level (categorized using number of years of schooling as follows: 
0–11, 12–13, >13).
Behavioral characteristics included cigarette smoking (non-
smoker, former smoker, or current smoker), alcohol intake (weekly 
frequency: ≤1 day, 2–6 days, daily), and physical activity level (classi-
fied based on the practice of vigorous, moderate, low-intensity physi-
cal activities, or none at least once a week) (10).
Health conditions included self-reported arthritis, cancer, heart 
disease, stroke, lung disease, and falls (within the last 2  years). 
Individuals with self-reported hypertension and/or mean systolic 
pressure ≥140 mmHg and/or diastolic ≥90 mmHg were considered 
hypertensive (11). Individuals with self-reported diabetes and/
or those with plasma glucose ≥126  mg/dL and/or glycated hemo-
globin ≥6.5% were considered diabetic (12). Women with hemo-
globin <12 mg/dL and men <13 mg/dL were considered anemic (13). 
Depressive symptoms were defined by the Center for Epidemiologic 
Studies Depression Scale (CES-D) score ≥4 (14). Memory score, our 
marker of cognitive function, was based on the summation of imme-
diate and delayed-recall results from a 10 word-list learning test 
(score range: 0–20) (15).
BMI was calculated by dividing mass in kilograms by height in 
square meters (kg/m2) and classified as follows: normal weight (18.5–
24.9 kg/m2), underweight (<18.5 kg/m2), overweight (25.0–29.9 kg/m2), 
and obese (≥30 kg/m2) (16). Because the relationship between muscle 
strength decline and abdominal obesity could be affected by weight 
change, particularly weight loss, we created a variable based on 
weight change between waves to adjust our models. This variable 
was categorized as follows: stable weight compared with previous 
wave, weight loss equal or superior to 5% compared with previ-
ous wave, and weight gain equal or superior to 5% compared with 
previous wave.
Blood measures: participants with hematological disorders, those 
who took anticoagulants, and those who declined to provide consent 
did not participate in the blood collection. Further information on 
the laboratory analyses are found elsewhere (17). The cutoff points 
for the biomarkers were as follows: triglycerides (≥150 mg/dL), total 
cholesterol (≥200 mg/dL), HDL (<40 mg/dL for men and <50 mg/dL 
for women), LDL (≥100 mg/dL) (18), C-reactive protein (≥3 mg/L), 
fibrinogen (>3.8 g/L) (19), and ferritin (<39 ng/mL for women and 
<62 ng/mL for men) (8). Disability: Physical functioning was meas-
ured using self-reported limitations in the following basic activities 
of daily living: dressing, walking across a room, bathing or shower-
ing, eating, getting in or out of bed, using the toilet; and in the fol-
lowing instrumental activities of daily living: making telephone calls, 
shopping for groceries, preparing hot meals, doing work around the 
house or garden, taking medications, and managing money, such as 
paying bills and keeping track of expenses. Both variables were used 
quantitatively based on the number of limitations (range: activities 
of daily living 0–6; instrumental activities of daily living 0–7) (20).
Statistical Analysis
Baseline characteristics were expressed as means and proportions. 
Differences between (a) included and excluded individuals (due to 
missing data) and (b) gender and abdominal obesity status were ana-
lyzed using chi-square tests, analysis of variance, and post hoc Tukey 
tests. A p value <.05 was used to indicate statistical significance.
Generalized linear mixed models were performed to estimate the 
trajectories in muscle strength decline in nonabdominal obese and 
abdominal obese participants, using the XTMIXED command of 
STATA 14 (StataCorp, College Station, TX). These models best han-
dle unbalanced data from studies with repeated measures and enable 
the statistical modeling of changes in a time-dependent outcome var-
iable (handgrip strength), as well as allowing time-dependent change 
in the magnitude of association between variables (21,22).
Because of significant differences in the intercept and slope values 
for muscle strength between men and women (p < .01) and also gen-
der differences in the rate of muscle strength decline (1,3), all analy-
ses were stratified by gender according to abdominal obesity status. 
The two final models, that is, one for each gender, included the inter-
action between time (denoting years of follow-up) and abdominal 
obesity status adjusted by all the covariates previously described.
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The intercept represents the estimated mean difference in mus-
cle strength between individuals with and without abdominal obe-
sity (reference category) at baseline. On the slope, time (in years) 
indicates whether the trajectory in muscle strength decline occurs 
independently of the presence of covariates (whether time per se is a 
determinant for this decline). The time by abdominal obesity interac-
tion (Time × Abdominal Obese) represents the estimated difference 
in the annual rate of change (slope) between abdominal obese par-
ticipants and the reference (nonabdominal obese) in muscle strength 
decline. The decline rates in grip strength were compared using β 
coefficients and 95% confidence intervals.
Two comparative analyses stratified by gender were performed. 
First, we tested whether muscle strength decline over time for over-
weight or obese participants according to BMI differed from the one 
observed according to abdominal obesity, that is, waist circumfer-
ence. The other comparative analysis, tested as the main outcome 
grip strength normalized by BMI values as a function of abdominal 
obesity status.
Results
Of the 7,666 individuals who participated in the baseline health 
examination (2004–2005), 2,485 were excluded due to missing data 
on grip strength, waist circumference, or covariates, resulting in a 
final sample of 5,181 individuals. Of this final sample, 4,026 and 
3,511 were reassessed at 4 and 8 years of follow-up, respectively.
Table  1 shows the characteristics of participants at baseline 
according to sex and abdominal obesity status. Participants excluded 
due to missing data were older, weaker, more abdominal obese, and 
more functionally compromised than those included in present 
study. They also had lower levels of education and wealth, had less 
conjugal life and hypertension, smoked more, and reported more 
sedentary lifestyle, anaemia, diabetes, arthritis, cancer, stroke, heart 
disease, falls, and depressive symptoms than those included. In addi-
tion, excluded participants had higher concentrations of C-reactive 
protein (CRP) and triglycerides as well as lower concentrations of 
high-density lipoprotein (HDL) and low-density lipoprotein (LDL) 
(p < .05; Supplementary Table 1).
The prevalence of abdominal obesity at baseline was higher 
among women (53.9%) than men (42.9%). The same occurred at the 
follow-up: 2008–2009 (60.1% vs 47.4%, respectively) and 2012–
2013 (58.7% vs 45.3%, respectively; p < .01 for all comparisons).
Table  2 displays the estimated parameters of the generalized 
linear mixed models for the change in grip strength as a function 
of abdominal obesity status over the 8-year follow-up period for 
women and men, respectively. In these models, abdominal obese men 
and women began at an intercept with greater muscle strength than 
their nonabdominal obese counterparts (p < .01). However, only 
abdominal obese men had an accelerated decline in strength over time 
(−0.12 kg/year; 95% confidence interval: −0.24 to −0.01). Moreover, 
the estimated change over time in muscle strength remained stable in 
the reference groups in both genders (when all covariates were either 
zero or mean values). The estimated annual change on handgrip 
strength values in abdominal and nonabdominal men and women is 
shown in Figure 1 and Supplementary Table 2.
The first comparative analysis using only BMI categories 
(Table  3) revealed similar findings to our main analysis that used 
only waist circumference as a measure of obesity. We found that 
obese men (BMI > 30.0 kg/m2) start with a greater muscle strength, 
but their decline over time in muscle strength was faster compared 
with those with normal weight men. This association was not found 
among overweight men. An important finding relates to the fact that 
45% of abdominal obese men (defined according to waist circum-
ference  [WC]) were also overweight (BMI) at baseline (Table  1). 
Therefore, despite overweight men (BMI) not being identified as at 
risk of decline in muscle strength, they were at greater risk based on 
their waist circumference, that is, abdominal obesity.
The intercept values found in the comparative analysis testing 
grip strength normalized by BMI values as a function of abdomi-
nal obesity status showed that abdominal obese men and women 
had weaker muscle strength compared with reference category 
(Supplementary Table  3). These findings are opposite to the ones 
from the main analysis using handgrip strength absolute values as 
the main outcome measure. Furthermore, abdominal obese women 
showed significant annual increases in muscle strength (slope). 
Therefore, the use of grip strength normalized by BMI is not a good 
analytical approach as waist circumference and BMI are highly cor-
related (Pearson’s correlation coefficient =  .80; p < .05), and, ulti-
mately, both outcome and exposure would have a body fat measure.
Discussion
In this large population-based cohort of older adults, we demon-
strated that older abdominal obese men have a faster rate of decline 
in muscle strength over 8 years of follow-up, despite their stronger 
muscle strength at baseline. In addition, abdominal adiposity meas-
ured by WC seems to be a better predictor than BMI at identifying 
individuals at risk of an accelerated loss in muscle strength. In our 
analyses, the association observed between abdominal obesity and 
decline in muscle strength was independent of confounders: age, 
economic circumstances and a wide range of health conditions, 
lifestyle, biomarkers, physical function, depression, and cognitive 
function.
Waist circumference is a more adequate measure for the evalu-
ation of adiposity in older adults (23) because body composition in 
this population can change independently of variations in total mass 
(3) and BMI can fail to diagnose up to 50% of obesity cases (24).
Our findings differ partially from the ones reported by Koster 
and colleagues (25), who analyzed longitudinal data from 2,307 
men and women (aged 70–79 years) from the Health, Aging, and 
Body Composition Study. They found that greater total fat mass 
(evaluated using dual-energy X-ray absorptiometry  [DEXA]) was 
associated with greater muscle strength at baseline in both sexes but 
did not find that greater fat mass exacerbated the muscle strength 
decline. However, the quantification of total fat mass in this study 
(25) does not indicate body fat distribution, which is an important 
information. The adipose tissue characteristics are not homogene-
ous, and different consequences may occur depending on the loca-
tion of fat accumulation. For instance, greater abdominal fat may 
reflect greater inflammatory activity (5).
In a 22-year follow-up study of 963 men and women (aged 
30–73 years), Stenholm and colleagues (26) found that obese indi-
viduals (BMI ≥ 30 kg/m2) had a more accelerated decline in handgrip 
strength compared with those in the ideal BMI group. Although obe-
sity classified according to BMI was a predictor of decline in muscle 
strength, it is not known what this association would be if the analy-
ses were stratified by sex.
Abdominal adiposity consists of subcutaneous and visceral fat 
with distinct proportions for men and women (5). Men accumu-
late fat predominantly in the visceral abdominal region, which is 
strongly associated with elevated expression of proinflammatory 
cytokines (5,27) and insulin resistance (28). These associations 
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Table 1. Baseline Characteristics by Gender and Abdominal Obesity Status of 5,181 Older Adults From the English Longitudinal Study of Aging (2004–2005)
Women Men
(n = 2,827) 54.6% (n = 2,354) 45.4%
Non-abdominal 
Obese (n = 1,302) Abdominal Obese (n = 1,525)
Non-abdominal 
Obese (n = 1,345) Abdominal Obese (n = 1,009)
Age, years 65.8 (9.7) 66.0 (9.3) 65.7 (9.2) 65.7 (9.0)
Marital status (with conjugal 
life), (%)
61.2* 61.9* 75.5†* 79.9†*
Wealth (quintiles), (%)
 Lowest quintile 27.1† 18.7†* 26.4† 21.3†*
 Second quintile 21.7† 19.2†* 25.2† 23.0†*
 Third quintile 19.3† 21.7†* 19.6† 22.0†*
 Fourth quintile 17.4† 20.4†* 16.2† 19.1†*
 Highest quintile 13.5† 18.0†* 11.5† 13.7†*
 Not declared 1.0† 2.0†* 1.1† 0.9†*
Schooling, (%)
 0–11 years 50.0†* 57.2†* 39.8†* 46.8†*
 12–13 years 26.9†* 24.3†* 24.8†* 24.8†*
 >13 years 23.1†* 18.5†* 35.4†* 28.4†*
Physical activity level, (%)
 Sedentary 3.1†* 3.8†* 2.9†* 3.6†*
 Low 12.8†* 20.5†* 8.3†* 15.0†*
 Moderate 51.8†* 53.0†* 49.5†* 52.2†*
 Vigorous 32.3†* 22.7†* 39.3†* 29.2†*
Alcohol intake, (%)
 ≤1 day 38.1†* 45.0†* 21.0†* 26.9†*
 2–6 days 39.6†* 35.0†* 48.0†* 44.5†*
 Daily 14.8†* 11.9†* 22.7†* 18.6†*
 Not declared 7.5†* 8.1†* 8.3†* 10.0†*
Smoking, (%)
 Non-smoker 47.0†* 43.1†* 31.0†* 25.3†*
 Former smoker 39.5†* 43.6†* 53.5†* 63.1†*
 Current smoker 13.5†* 13.3†* 15.5†* 11.6†*
Stroke (yes), (%) 1.1 1.2 1.1 0.9
Anaemia (yes), (%) 6.4† 4.3† 5.6 5.0
Cancer (yes), (%) 2.7 2.4* 2.0† 4.2†*
Heart disease (yes), (%) 6.8 8.2 7.3 7.9
Diabetes (yes), (%) 1.0†* 4.8†* 4.1†* 7.4†*
Arthritis (yes), (%) 33.9†* 45.2†* 22.7†* 31.5†*
Hypertension (yes), (%) 36.5† 48.1† 39.4 49.4
Osteoporosis (yes), (%) 10.9†* 8.2†* 1.3* 2.1*
Lung disease (yes), (%) 11.7† 15.5† 12.3 15.1
Fall (yes), (%) 22.9†* 25.9†* 15.1* 16.5*
Cognition (mean), points 10.7 (3.5)†* 10.4 (3.4)†* 9.9 (3.4)* 9.7 (3.2)*
Depressive symptoms (yes), (%) 14.6†* 18.1†* 8.5* 10.6*
Handgrip (kg), (mean) 23.8 (6.7)* 24.2 (6.7)* 39.5 (9.7)†* 41.1 (10.0)†*
Waist circumference (cm), (mean) 79.9 (5.7)†* 99.0 (8.9)†* 93.4 (6.4)†* 110.6 (7.1)†*
Body mass index (kg/m2), (mean) 24.0 (2.8)†* 30.9 (4.6)† 25.2 (2.5)†* 30.7 (3.2)†
 Normal weight (%) 61.6†* 4.7†* 42.5†* 0.9†*
 Underweight (%) 2.2†* 0.0†* 1.0†* 0.0†*
 Overweight (%) 34.7†* 42.7†* 54.1†* 45.0†*
 Obese (%) 1.5†* 52.6†* 2.4†* 54.1†*
Triglycerides (≥150 mg/dL), (%) 26.6†* 48.5†* 37.2†* 55.8†*
Total cholesterol  
(≥200 mg/dL), (%)
83.0†* 78.9†* 66.2†* 61.4†*
HDL (<40 mg/dL ♂;  
<50 mg/dL ♀), (%)
12.5†* 26.5†* 3.6† 9.3†*
LDL (≥100 mg/dL), (%) 90.7†* 87.5†* 82.6† 77.2†*
C-reactive protein (>3 mg/L), (%) 22.4† 49.6†* 25.5† 41.3†*
Fibrinogen (>380 mg/dL), (%) 13.8† 21.0†* 14.5 16.7*
Ferritin (<39 ng/mL ♂;  
<62 ng/mL ♀), (%)
22.2† 18.7† 23.1† 17.9†
ADL (mean of impairments) 0.2 (0.7)† 0.4 (0.9)† 0.2 (0.7)† 0.4 (0.9)†
IADL (mean of impairments) 0.3 (0.8)†* 0.4 (0.9)†* 0.2 (0.7)* 0.2 (0.7)*
Notes: Data expressed as proportion, mean, and standard deviation. 
Abbreviations: ADL = basic activities of daily living; HDL = high-density lipoprotein; IADL = instrumental activities of daily living; LDL = low-density lipoprotein.
*Difference between sexes within same abdominal obesity status (p < .05). †Difference between states of abdominal obesity within same sex (p < .05).
4 Journals of Gerontology: MEDICAL SCIENCES, 2018, Vol. XX, No. XX
D
ow
nloaded from
 https://academ
ic.oup.com
/biom
edgerontology/advance-article-abstract/doi/10.1093/gerona/gly178/5068954 by U
niversity C
ollege London user on 13 D
ecem
ber 2018
may mediate the accelerated decline in muscle strength observed in 
abdominal obese men.
The increase in proinflammatory cytokines seems to exacerbate mus-
cle catabolism by raising levels of IL-6, TNF-α, and TNF-β (27); depress-
ing the anabolic process through the increase in TNF-α and TNF-β levels 
(27,29); and negatively affecting the muscle tissue repair (suppression 
of IGF-1 repair agent) (30), consequently leading to a greater loss of 
muscle strength (3,6). Moreover, in the present study, diabetes was more 
frequent among abdominal obese men at baseline. Insulin resistance may 
compromise muscle anabolism (28), break down protein for energy pur-
poses, and trigger a greater loss of muscle strength (31).
Visceral fat is also strongly associated with elevated triglycerides 
levels and fatty infiltration of muscle tissue (32,33). Evidence indi-
cates that intramuscular fat may cause cellular apoptosis resulting 
in less strength (33). Although no inferences can be made regarding 
the amount of intramuscular fat in the present study, hypertriglyceri-
demia was more frequent among abdominal obese men at baseline, 
and such individuals could also have greater fatty infiltration.
In our sample, the prevalence of abdominal obesity was higher 
in women, but this fact was not associated with a faster rate of 
decline in muscle strength. The absence of such an association is not 
well understood, but characteristics regarding the accumulation of 
abdominal fat in women seem to help them to have a more favora-
ble muscle strength trajectory in middle to older age compared 
with men.
Young women have more subcutaneous fat in their hips and 
thighs. At about the age of 50  years, women undergo an acceler-
ated redistribution of fat to the subcutaneous abdominal region, 
characterized by less inflammatory activity in comparison with 
visceral fat and involving greater release of circulating fatty acids 
(5,32). Although abdominal obese women had higher C-reactive 
protein and fibrinogen plasma levels at the baseline, these are not 
good markers of abdominal obesity such as IL-6, TNF-α, and TNF-β 
(27,29).
A potential explanation for waist circumference not being able 
to predict a faster rate of muscle strength decline in women could 
be because women accumulate more subcutaneous fat, whereas men 
accumulate more visceral fat. Subcutaneous fat might be protective 
against the dangers of visceral fat.
Future research should investigate the waist-to-hip ratio as a pro-
tective measure for this outcome in women because it reflects greater 
adiposity in the lower trunk and hips (34). This was not done in our 
study because there were only two measures of this information in 
the follow-up. The effect of abdominal obesity as a risk factor for 
worse physical mobility trajectories as well as lower extremity func-
tion should also be explored.
Our study has several strengths and potential limitations that 
need to be acknowledged. The major strength is the use of a large 
nationally representative sample of community-dwelling English 
people aged 50 years and older as well as the use of objective health 
measures (WC, BMI, handgrip strength, and blood analytes). Our 
analyses included data from three waves and had a long follow-up 
period. The models were adjusted by a wide range of important 
covariates associated with both outcome and exposure. Finally, 
Table 2. Generalized Linear Mixed Models Estimates for Handgrip 
Values as a Function of Abdominal Obesity Status Over an 8-Year 
Follow-up Period
Women Men
n = 2,827 n = 2,354
Estimated Parameter (95% CI)
Intercept (baseline)
Non-abdominal Obese Reference Reference
Abdominal Obese 0.84 (0.45–1.23)** 1.56 (0.97–2.15)**
Slope (follow-up)
Time, years −0.04 (−0.57–0.50) −0.58 (−1.29–0.16)
Time × Non-abdominal 
Obese
Reference Reference
Time × Abdominal Obese −0.03 (−0.11–0.06) −0.12 (−0.24–−0.01)*
Notes: All models adjusted by socioeconomic variables, behavioral charac-
teristics, health conditions, depression, cognition, serum markers, and disabil-
ity. Abbreviation: CI = confidence interval.
*p < .05. **p < .01.
Figure 1. Trajectories of handgrip strength according to abdominal obesity 
status over time (2004–2005 to 2012–2013). Predictions for individuals aged 
50 years; with conjugal life; in highest wealth quintile; with higher level of 
education; nonsmokers; with little or no alcohol intake; practicing vigorous 
physical exercise; stable weight; without arthritis, cancer, heart disease, 
stroke, lung disease, osteoporosis, hypertension, diabetes, anemia, or falls; 
with CES-D < 4; mean memory score = 20; without functional limitations; and 
without abnormal concentrations of triglycerides, total cholesterol, LDL, HDL, 
C-reactive protein, fibrinogen, and ferritin. Abbreviation: CES-D = Center for 
Epidemiologic Studies Depression Scale.
Table 3. Generalized Linear Mixed Models Estimates for Handgrip 
Values as a Function of Body Mass Index Over an 8-Year Follow-up: 
A Comparative Analysis
Women Men
n = 2,827 n = 2,354
Estimated Parameter (95% CI)
Intercept (baseline)
 Normal weight Reference Reference
 Underweight −0.03 (−1.87–1.80) −2.92 (−6.58–0.73)
 Overweight 1.00 (0.57–1.48)** 1.50 (0.80–2.21)**
 Obese 1.47 (0.94–2.01)** 3.26 (2.38–4.14)**
Slope (follow-up)
 Time, years −0.00 (−0.54–0.53) −0.44 (−1.17–0.29)
 Time × Normal weight Reference Reference
 Time × Underweight −0.12 (−0.53–0.28) 0.27 (−0.68–1.23)
 Time × Overweight −0.06 (−0.16–0.03) −0.03 (−0.16–0.10)
 Time × Obese −0.06 (−0.17–0.04) −0.17 (−0.33–−0.01)*
Notes: All models adjusted by socioeconomic variables, behavioral charac-
teristics, health conditions, depression, cognition, serum markers, and disabil-
ity. Abbreviation: CI = confidence interval.
*p < .05. **p < .01.
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additional analyses were performed to address any potential ques-
tions about the obesity measure used. The findings from the com-
parative analyses support the hypothesis that greater abdominal fat 
is an important predictor of decline in muscle strength in men.
Limitations arise from the fact that participants excluded from 
our analyses due to missing data at baseline were older and weaker, 
and had more abdominal obesity. Therefore, the association between 
abdominal obesity and accelerated muscle strength decline may have 
been underestimated. Nevertheless, we could show that abdominal 
obese men had greater muscle strength decline. Secondly, there were 
no information about participants’ dietary habits or their history of 
abdominal obesity. Such information could contribute to a better 
understanding of the effect of abdominal adiposity on the decline in 
muscle strength. Lastly, waist circumference does not provide direct 
estimates of visceral adiposity (pathogenic) such as computerized 
tomography or magnetic resonance imaging. However, it is a useful 
clinical screening tool.
In summary, abdominal obesity affects the muscle strength 
decline differently in men and women. Abdominal obese men are 
at greater risk of accelerated muscle strength decline. In addition, 
abdominal obesity defined by waist circumference seems to be a bet-
ter measure to identify older adults at risk of muscle strength decline 
compared with BMI, especially in men. Our main findings highlight 
the importance of abdominal obesity in the prevention of muscle 
strength loss in older adults, especially in men. Because abdominal 
obesity can be controlled, its metabolic impact and associated costs 
to the loss of muscle strength can be prevented or reduced.
Supplementary Material
Supplementary data are available at The Journals of Gerontology, 
Series A: Biomedical Sciences and Medical Sciences online.
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